Pharmaceutical Service of Clinical Pharmacists in Hypertension with Hyperhomocysteinemia

OBJECTIVE To explore the pharmaceutical service of clinical pharmacists of cardiovascular medicine in hypertension with hyperhomocysteinemia, and to reflect its value in safe, reasonable and effective drug use. METHODS Clinical pharmacists participated in the whole treatment process of a young patient with hypertension accompanied by hyperhomocysteinemia. Combined with the patient's specific condition, clinical pharmacist applied their professional knowledge of pharmacy to assist clinicians in formulating treatment plans for lowering blood pressure, heart rate and homocysteine level from the aspects of drug selection, dose recommendation, safety and effectiveness, and to carry out pharmaceutical monitoring, and analyzed and summarized the pharmaceutical care of clinical pharmacist in this disease. RESULTS According to the patient's blood pressure and heart rate, bisoprolol fumarate and ivabradine hydrochloride were successively used to control the heart rate and blood pressure. Clinical pharmacists suggested the use of folic acid to control the homocysteine levels. The patient's blood pressure and heart rate turned to normal, and homocysteine had basically decreased to normal level after three months treatment. CONCLUSION Clinical pharmacists analyze and suggest the drug selection of patients with hypertension accompanied by hyperhomocysteine, and provide them with high-quality and individualized pharmaceutical care, which improve the safety, rationality and effectiveness of drug therapy.